1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Tuberculosis, MDR: new trials by email Literature Review of Tuberculosis, MDR trials Research Report on Tuberculosis, MDR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis Bedaquiline, Linezolid, Pretomanid - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 2 / Phase 3 | Recruiting | University of California, San Francisco | 400 | 2025-10-03 | 2026-09-02 |
Tuberculosis (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Pulmonary (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Linezolid (1) · Moxifloxacin (1) · bedaquiline (1) · pretomanid (1)
University of California, San Francisco (1)
Mongolia (1) · Pakistan (1) · Peru (1) · Uganda (1) · Vietnam (1)